ConductScience.org, home

Paper2178709

Chronic graft-versus-host disease.

Atkinson K. Bone Marrow Transplant, 1990. Cited by 180 papers, by iCite.

Cite this record

ConductScience Library. Chronic graft-versus-host disease. Papers, record 2178709. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2178709

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chronic graft-versus-host disease.
PubMed
Journal
Bone Marrow Transplant
PubMed
Year
1990
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
180
iCite
Relative citation ratio, by iCite
6.58
iCite
Revised in PubMed
2005-11-16
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Atkinson KK

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Graft vs Host DiseaseMajor topic
Chronic Disease
Humans

Cited by36

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 180 citations.

PMIDTitleJournalYearIn PapersSource
39246931Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Patients With Dry Eye Disease Associated With Ocular Graft-Versus-Host Disease.Cureus2024https://conductscience.org/library/papers/39246931PubMed
38312919Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host Disease.J Health Econ Outcomes Res2024https://conductscience.org/library/papers/38312919PubMed
37842497Topical Spironolactone in the Treatment of Ocular Graft-Versus-Host Disease.Cureus2023https://conductscience.org/library/papers/37842497PubMed
35240319Adoptive transfer of ex vivo expanded regulatory T cells improves immune cell engraftment and therapy-refractory chronic GvHD.Mol Ther2022https://conductscience.org/library/papers/35240319PubMed
30674472How I treat refractory chronic graft-versus-host disease.Blood2019https://conductscience.org/library/papers/30674472PubMed
30546069Donor lymphocyte infusions for B-cell malignancies relapse after T-cell replete allogeneic hematopoietic cell transplantation.Bone Marrow Transplant2019https://conductscience.org/library/papers/30546069PubMed
27374825Glycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity?Croat Med J2016https://conductscience.org/library/papers/27374825PubMed
26538747Lichenoid Variant of Chronic Cutaneous Graft Versus Host Reaction Post Blood Transfusion: A Rare Event Post Blood Transfusion.Indian J Dermatol2015https://conductscience.org/library/papers/26538747PubMed
25355659Extracorporeal photopheresis for graft-versus-host disease: the role of patient, transplant, and classification criteria and hematologic values on outcome-results from a large single-center study.Transfusion2015https://conductscience.org/library/papers/25355659PubMed
25256376Effect of exercise therapy on muscle mass and physical functioning in patients undergoing allogeneic hematopoietic stem cell transplantation.Support Care Cancer2015https://conductscience.org/library/papers/25256376PubMed
25003927Histopathologic diagnosis of chronic graft-versus-host disease of the oral mucosa according to the National Institutes of Health Consensus.Einstein (Sao Paulo)2014https://conductscience.org/library/papers/25003927PubMed
23986066Expression and localization of aging markers in lacrimal gland of chronic graft-versus-host disease.Sci Rep2013https://conductscience.org/library/papers/23986066PubMed
22659679Possible involvement of cytokines, chemokines and chemokine receptors in the initiation and progression of chronic GVHD.Bone Marrow Transplant2013https://conductscience.org/library/papers/22659679PubMed
20307722Chronic graft-versus-host disease (GVHD) in children.Pediatr Clin North Am2010https://conductscience.org/library/papers/20307722PubMed
19770713High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen.Cornea2009https://conductscience.org/library/papers/19770713PubMed
18978736Innovative approaches to treat steroid-resistant or steroid refractory GVHD.Bone Marrow Transplant2008https://conductscience.org/library/papers/18978736PubMed
18850020Alefacept treatment for refractory chronic extensive GVHD.Bone Marrow Transplant2009https://conductscience.org/library/papers/18850020PubMed
17947475High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.Clin Cancer Res2007https://conductscience.org/library/papers/17947475PubMed
17417662New clinical grading system for chronic GVHD predicts duration of systemic immunosuppressive treatment and GVHD-specific and overall survival.Bone Marrow Transplant2007https://conductscience.org/library/papers/17417662PubMed
15701727New approaches for preventing and treating chronic graft-versus-host disease.Blood2005https://conductscience.org/library/papers/15701727PubMed

See all 36 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2178709

GET https://conductscience.org/api/papers/v1/2178709/cited_by?page=2